Product Images Nicardipine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Nicardipine Hydrochloride NDC 69097-007 by Cipla Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pouch-label-20mg - pouch label 20mg

pouch-label-20mg - pouch label 20mg

This is a description of a medication with the NDC 69097-007-45. It contains Nicardipine Hydrochloride in 0.9% Sodium Chloride injection for intravenous infusion. The medication is sterile and nonpyrogenic with a concentration of 20 mg in 200 mL (0.1 mg/mL). The package insert should be consulted for complete information on dosage and administration. It is essential to check for leaks, ensure the solution is clear, avoid adding supplemental medication, and not use in series connections. Storage instructions include keeping it at 21°C to 25°C, protecting from freezing and excessive heat, and storing in the carton until ready to use.*

pouch-label-40mg - pouch label 40mg

pouch-label-40mg - pouch label 40mg

This text provides information about a medication containing Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection for intravenous infusion. The medication comes in a 40 mg in 200 mL solution with a concentration of 0.2 mg/mL. It is sterile and nonpyrogenic with iso-osmotic characteristics. The text also includes instructions for usage, dosage, caution regarding leaks, storage conditions, manufacturer details, and a reminder to protect the solution from light.*

structure - structure

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.